|Bid||0.0000 x 1200|
|Ask||0.0000 x 1400|
|Day's Range||3.0900 - 3.3100|
|52 Week Range||2.7500 - 16.2000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||15.71|
|Earnings Date||Aug 10, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.25|
Subscribe to Yahoo Finance Plus to view Fair Value for HLTH
Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed Suzanne Stone as its new Chief Commercial Officer. Stone brings over 25 years of experience building high- performing sales and marketing organizations in rapidly growing biotech and medical device companies, most recently at DexCom, Inc.
To get a sense of who is truly in control of Cue Health Inc. ( NASDAQ:HLTH ), it is important to understand the...
Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed David Tsay, MD, PhD, as its Chief Medical Officer. Dr. Tsay comes to Cue with more than 20 years of experience in clinical medicine, research, and health technology. Most recently, Dr. Tsay served at Apple, where he led an Apple Health clinical team in developing new Health products, including FDA-cleared products in cardiovascular health.